NuGenomics Company Profile

Background

NuGenomics, established in 2018 and headquartered in New Delhi, India, is a genetic research organization dedicated to enhancing individual health through personalized genomic insights. The company leverages advanced machine learning (ML) and artificial intelligence (AI) technologies to analyze genetic, physiological, and physical data, providing comprehensive health assessments and tailored lifestyle recommendations.

Key Strategic Focus

NuGenomics focuses on integrating genomic data with AI/ML systems to deliver personalized health solutions. The company's core objectives include:

• Personalized Health Assessments: Utilizing genetic testing to identify predispositions to various health conditions.

• Tailored Lifestyle Recommendations: Offering actionable suggestions based on individual genetic profiles to optimize health and prevent diseases.

• Holistic Wellness Programs: Developing comprehensive programs addressing weight management, diabetes care, and overall wellness.

The primary markets targeted by NuGenomics encompass individuals seeking personalized health insights and organizations aiming to provide health benefits to their employees.

Financials and Funding

NuGenomics has secured funding through multiple rounds:

• Accelerator/Incubator Funding: In September 2020, the company received support from India Accelerator.

• Seed Round: In June 2021, NuGenomics raised an undisclosed amount from investors including Lyxel&Flamingo.

• Later Stage Venture Capital: In October 2023, the company secured $500,000 in funding.

These funds are intended to enhance technological capabilities, expand service offerings, and scale operations.

Pipeline Development

NuGenomics offers a range of products and services, including:

• Genetic Test Report: Priced at ₹8,999, this report helps individuals understand their predispositions toward cholesterol levels, blood sugar levels, and other health conditions.

• DNA-Based Health Programs: These include weight loss and gain programs, as well as holistic wellness programs, typically spanning 111 days and priced between ₹10,000 and ₹18,000.

The company is also developing products focusing on women's health, such as PCOS testing, and immunity-related health products.

Technological Platform and Innovation

NuGenomics differentiates itself through its proprietary technological platforms:

• AI/ML Integration: The company employs AI and ML algorithms to analyze approximately 5 million data points per individual, enabling precise health assessments and recommendations.

• Genomic Data Analysis: By focusing on genetic markers relevant to the Indian population, NuGenomics ensures the accuracy and applicability of its health insights.

Leadership Team

• Rahul Ranganathan: Co-Founder and Chief Executive Officer. Rahul holds a master's degree in molecular biology and an MBA from XLRI Jamshedpur. He has experience at organizations like PepsiCo and Flipkart, combining business acumen with scientific expertise.

• Dr. Balamurali AR: Co-Founder and Chief Technology Officer. Dr. Balamurali has a background in technology and research, with previous roles at Alcovia Technologies, Samsung, and Cognizant, and postdoctoral research experience in France.

Competitor Profile

Market Insights and Dynamics

The genetic testing market in the Asia-Pacific region is projected to grow at a compound annual growth rate (CAGR) of 7.65%, reaching $15.33 billion by 2027. Factors contributing to this growth include increased disposable income, higher healthcare expenditure, and a rising prevalence of chronic diseases.

Competitor Analysis

Key competitors in the personalized genetic testing and health assessment market include:

• Mapmygenome: Offers DNA testing services focusing on health and wellness.

• The Gene Box: Provides genetic testing and personalized health solutions.

• MedGenome Labs: Specializes in genetic diagnostics and research.

• Strand Life Sciences: Offers genomic testing and bioinformatics services.

• Centogene: Focuses on rare disease diagnostics through genetic testing.

• Eurofins Product Testing: Provides a range of testing services, including genetic analysis.

Strategic Collaborations and Partnerships

NuGenomics has established partnerships with several organizations to expand its reach and service offerings:

• Corporate Collaborations: The company has conducted genetic testing for employees of companies such as Myntra, CarDekho, Gameskraft, Purple Quarters, and Aveva.

Operational Insights

NuGenomics differentiates itself by:

• Population-Specific Genetic Markers: Focusing on genetic markers relevant to the Indian population to enhance the accuracy of health assessments.

• AI-Driven Analysis: Utilizing AI to process extensive data points, providing comprehensive and precise health recommendations.

Strategic Opportunities and Future Directions

NuGenomics aims to:

• Expand Product Offerings: Develop new health products focusing on women's health and immunity.

• Enhance Technological Capabilities: Continue integrating advanced AI/ML technologies to improve service accuracy and personalization.

• Broaden Market Reach: Strengthen partnerships with organizations and expand direct-to-consumer services to increase market penetration.

Contact Information

• Website: nugenomics.in

• LinkedIn: NuGenomics

• Instagram: @nugenomics

• Facebook: NuGenomics

Note: Specific contact details such as address, phone number, and email are not provided in this profile.